Testing effectiveness (Phase 2)Ended earlyNCT01863225
What this trial is testing
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Who this might be right for
DyslipidemiaCoronary Artery Disease
Resverlogix Corp 13